Edition:
United States

CVS Health Corp (CVS.N)

CVS.N on New York Stock Exchange

79.63USD
22 Sep 2017
Change (% chg)

$0.07 (+0.09%)
Prev Close
$79.56
Open
$79.20
Day's High
$79.90
Day's Low
$78.64
Volume
1,661,236
Avg. Vol
1,432,911
52-wk High
$90.85
52-wk Low
$69.30

Chart for

About

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other... (more)

Overall

Beta: 0.92
Market Cap(Mil.): $80,949.05
Shares Outstanding(Mil.): 1,016.57
Dividend: 0.50
Yield (%): 2.51

Financials

  Industry Sector
P/E (TTM): -- 21.33 16.08
EPS (TTM): -- -- --
ROI: -- 11.96 14.60
ROE: -- 13.65 14.03

BRIEF-CVS Health responds to opioid situation in the U.S.

* Says "in addition to our legacy opioid-abuse prevention programs, we are adding a new suite of tools‍​"‍​

Sep 21 2017

UPDATE 2-Walgreens gets regulatory nod for slimmed-down Rite Aid deal

Sept 19 U.S. antitrust regulators have allowed a slimmed-down deal for drugstore chain Walgreens Boots Alliance Inc to buy about 42 percent of Rite Aid Corp's U.S. stores for $4.38 billion, Walgreens said on Tuesday.

Sep 19 2017

CVS defeats generic drug overcharging class action

By Nate Raymond A federal judge has dismissed a class action lawsuit accusing pharmacy chain CVS Health Corp of systematically overcharging people who bought generic drugs using insurance rather than cash.

Sep 06 2017

CVS Health's dull third-quarter forecast overshadows profit beat

CVS Health Corp forecast current quarter profit below Wall Street estimates and said it has been ordered to cooperate with investigations into possible false claims submitted to a government healthcare program and drug pricing.

Aug 08 2017

UPDATE 3-CVS Health's dull Q3 forecast overshadows profit beat

* Shares down 1.4 pct (Adds investor comment, company response; updates shares)

Aug 08 2017

BRIEF-CVS Health received civil investigative demand from Attorney General of Minnesota

* CVS Health Corp - in July 2017, co received a civil investigative demand from the attorney general of Minnesota - sec filing

Aug 08 2017

BRIEF-CVS Health reports Q2 GAAP earnings per share $1.07 from continuing operations

* Q2 gaap earnings per share $1.07 from continuing operations

Aug 08 2017

CVS Health's quarterly profit jumps 19 pct

Aug 8 CVS Health Corp, the No.2 U.S. drugstore chain by store count, reported an 18.8 percent rise in quarterly profit on Tuesday, as its pharmacy benefits management business serviced more claims and demand for its specialty pharmacy services rose.

Aug 08 2017

BRIEF-Wellcare Health Plans CFO says company and CVS Health have agreed to extend their pharmacy benefit manager agreement for 2019 and 2020

* Wellcare Health Plans CFO says company and CVS Health have agreed to extend their pharmacy benefit manager agreement for 2019 and 2020 - Conf Call Further company coverage:

Aug 04 2017

Two biggest U.S. drug purchasers keep key Novo Nordisk drugs on 2018 list

COPENHAGEN, Aug 2 U.S. pharmacy benefit manager (PBM), CVS Health, said late Tuesday it had kept Novo Nordisk's key drugs on its 2018 list, removing some uncertainty over the U.S. market for the world's top insulin maker.

Aug 02 2017

Earnings vs. Estimates